Liver transplantation in children;Transplante hepático em crianças

Jornal de Pediatria

Volumn 84, Issue 5, 2008, Pages 381-382

  Kelly, Deirdre A ^a,b  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; DACLIZUMAB; GANCICLOVIR; RAPAMYCIN; VALGANCICLOVIR;

CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; EDITORIAL; EPSTEIN BARR VIRUS; HEPATITIS; HUMAN; LIVER TRANSPLANTATION;

CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; GRAFT REJECTION; HUMANS; INFANT; LIVER FAILURE; LIVER TRANSPLANTATION; WAITING LISTS;

EID: 56049096515     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1833     Document Type: Editorial

References (13)

1. Kelly DA. Current results and evolving indications for liver transplantation in children. J Pediatr Gastroenterol Nutr. 1998;27:214-21.
2. Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldstein LI, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg. 2005;241:905-16.
3. Soltys KA, Mazariegos GV, Squires RH, Sindhi RK, Anand R, SPLIT Research Group. Late graft loss or death in pediatric liver transplantation: An analysis of the SPLIT database. Am J Transplant. 2007;7:2165-71.
4. Kelly DA. Nutritional factors affecting growth before and after liver transplantation. Pediatr Transplant. 1997;1:80-4.
5. de Ville deGoyet J, Hausleithner V, Reding R, Lerut J, Janseen M, Otte JB. Impact of innovative techniques on the waiting list and results in pediatric liver transplantation. Transplantation. 1993;56:1130-6.
6. Posfay-Barbe KM. Optimal approach to prevent CMV disease. Pediatr Transplant. 2008;12:385-7.
7. Haque T, Wilkie GM, Taylor C, Amlot PL, Murad P, Iley A, et al. Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet. 2002;360:436-42.
8. Kelly D, Jara P, Rodek B, Lykavieris P, Burdelski M, Becker M, et al. Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: randomised European multicentre trial. Lancet. 2004;364:1054-61.
9. Kelly DA. Current issues in pediatric transplantation. Pediatr Transplant. 2006;10:712-20.
10. Venick RS, McDiarmid SV, Farmer DG, Gornbein J, Martin MG, Vargas JH, et al. Rejection and steroid dependence: unique risk factors in the development of pediatric post transplant de novo autoimmune hepatitis. Am J Transplant. 2007;7:955-63.
11. Evans HM, McKiernan PJ, Beath SV, de ville de Goyet J, Kelly DA. Histology of liver allografts following paediatric liver transplantation. J Pediatr Gastroenterol Nutr. 2001;23:383.
12. Bucuvalas JC, Alonso E. Long-term outcomes after liver transplantation in children. Curr Opin Organ Transplant. 2008;13:247-51.
13. Mesquita MC, Ferreira AR, Veloso LF, Roquete ML, de Lima AS, Pimenta JR, et al. Pediatric liver transplantation: tem years of experience at a single center in Brazil. J Pediatr (Rio J). 2008;84:395-402